Tumor markers, including Beta-hCG, AFP, CA 19-9, CEA, and PSA, were negative, helping to exclude germ cell, gastrointestinal, and prostate tumors from the initial differential diagnosis based on the patient’s age, sex, and nodal distribution. The gene discussed is AFP; the disease is prostate neoplasm.